MEDIZONE (OTC: MZEI) — Best Product – Competitively Priced – Fastest Action
Written by StockGuru on July 2, 2009
Best Product — Best Price — Fastest Action
Medizone understands being the best product is not always enough. The company is also focused on having the BEST PRICE!
From a commercial viewpoint, the higher the “kill rate” in the shortest turn around time, the more favorably physicians and hospital administrators will view the system.
Medizone now believes that the performance profile of its AsepticSure Sterilization System will exceed all the prerequisite requirements of affordability, practicability and unmatched efficacy, which will catapult it into the world market.
Parallel Research to Confrim Medizone’s Trials
Medizone is serious about its research. It has a parallel research program with BioZone Corporation, Medizone’s engineering development partner.
BioZone confirmed the AsepticSure(TM) hospital sterilization system can charge a room of 1,065 cubic feet to our target ozone level in less than 15 minutes, which is followed by the ozone decontamination phase.
The same room can then be returned to a habitable standard (less than 0.02 ppm ozone) in 13 minutes using a separate ozone destruct technology. This confirms the start to finish time to complete the entire decontamination process can be achieved with minimal disturbance to normal hospital flow patterns.
BEST PRODUCT — BEST PRICE — REALLY AND TRULY SAVING LIVES, SAVING FAMILIES, SAVING HOPE
Contact:
Medizone International, Inc. (OTC: MZEI)
144 Buena Vista
P.O. Box 742
Stinson Beach, CA 94970
Web: http://www.medizoneint.com
Telephone: 415-868-0300
Fax: 415-868-2344
Investor Relations 800-953-3350
E-mail: operations@medizoneint.com
Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 200,000 144 restricted common shars by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This blog contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact in this announcement are forward-looking statements, including but not limited to,the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.
Submit Reply
